Sean Maduck - 02 May 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
President, Corcept Endocrinology
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Sean Nicholas Maduck
Issuer symbol
CORT
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
04 May 2022, 16:12:16 UTC
Previous filing
15 Feb 2023
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 02 May 2022 Common Stock 50,000 $22.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of April 6, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on April 6, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

President, Corcept Endocrinology